Regulatory requirements for submission and compilation of dossier for prescription medicines (parenterals) in Australia-TGA

By:

Language: English Publication details: Mysore JSSCP 2012Edition: 1Subject(s):

DDC classification:

Dissertation note: Pramod Kumar T.MJSS UniversityP.Regulatory Affairs

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

Holdings
Item type	Current library	Home library	Collection	Call number	Status	Barcode
Dissertation/Thesis	JSS College of Pharmacy, Mysuru	JSS College of Pharmacy, Mysuru	Pharmaceutics	615.48 NAR (Browse shelf(Opens below))	Available	D08267

Previous	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	Next
Previous	615.48 NAG Collation, compilation and comparison of cGMP, GLP & GDP for selected category of pharmaceutical products in India, US, EU, Singapore and UAE	615.48 NAG Summary technical document, common submission dossier template and regulated product submission of medical device	615.48 NAG Comparison of regulatory requirements with special emphasis on bioequivalence guidance for registration of generic drug product in Europe, Canada, Australia, Russia and Brazil	615.48 NAR Regulatory requirements for submission and compilation of dossier for prescription medicines (parenterals) in Australia-TGA	615.48 NAR European medicines agency organisational structure and authorisation procedure	615.48 NAV Comparative study for registration of generics in EU, US and an overview of administrative documents submitted in emerging markets	615.48 NAV Biosimilars: scientific, clinical and regulatory issues in regulated markets	Next